Citation:Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, et al 2002

From Cancer Guidelines Wiki

Citation

Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002 Dec 15;20(24):4665-72 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/12488411.



Critical appraisals

Critical appraisal link Clinical questionAssigned toStatus
What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first line setting?Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACPcompleted
What is the optimal systemic therapy and duration to be used for the treatment of limited stage small cell lung cancer?Associate Professor Michael Michael MBBS(Hons), BSc(Hons), MD, FRACPcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What is the optimal chemotherapy regimen and duration of therapy in extensive stage small cell lung cancer in the first line setting?